ANGPTL4尿

Ziwen Li1, Lipeng Guan1,2,3, Tong Mu1

  • 1Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, People's Republic of China.

Diabetes
|March 10, 2026
PubMed
概括

抗血管内皮生长因子4 (ANGPTL4) 在患有抗血管内皮生长因子 (抗VEGF) 治疗耐药的多发性糖尿病视网膜病变 (PDR) 的患者中升高. ANGPTL4促进视网膜的淋巴状重塑,这表明它是PDR的新治疗点.